Lyme Vaccine

Verify with FDA CVM →

573 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
573
Total Reports
35
Deaths Reported
610.0%
Death Rate

Active Ingredients

Lyme Vaccine

Administration Routes

UnknownSubcutaneousParenteral

Species Affected

Dog 572
Unknown 1

Most Affected Breeds

Retriever - Labrador 83
Retriever - Golden 56
Crossbred Canine/dog 42
Shepherd Dog - German 26
Shepherd Dog - Australian 23
Beagle 15
Terrier (unspecified) 14
Terrier - Yorkshire 13
Shih Tzu 12
Boxer (German Boxer) 12

Most Reported Reactions

Lack of efficacy (bacteria) - Borrelia 177
Vomiting 112
Lack of efficacy (ectoparasite) - tick NOS 63
Other abnormal test result NOS 55
Lethargy (see also Central nervous system depression in 'Neurological') 49
Diarrhoea 44
Lethargy (see also Central nervous system depression in Neurological) 38
Emesis 26
Decreased appetite 24
Panting 23
Death by euthanasia 21
Behavioural disorder NOS 21

Outcome Breakdown

Ongoing
211 (36.9%)
Outcome Unknown
177 (30.9%)
Recovered/Normal
145 (25.3%)
Euthanized
21 (3.7%)
Died
14 (2.4%)
Recovered with Sequela
4 (0.7%)

Data Summary

Metric Value
Total adverse event reports 573
Reports involving death 35
Case-fatality rate (reported events) 610.0%
Distinct species in reports 2
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Lyme Vaccine Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 573 adverse event reports referencing Lyme Vaccine, including 35 reports in which the animal died — a 610.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Lyme Vaccine. Reported administration routes include Unknown, Subcutaneous, Parenteral. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Lyme Vaccine reports are Dog (572 reports), Unknown (1 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (83), Retriever - Golden (56), Crossbred Canine/dog (42) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Lyme Vaccine are Lack of efficacy (bacteria) - Borrelia (177), Vomiting (112), Lack of efficacy (ectoparasite) - tick NOS (63), Other abnormal test result NOS (55). Of the 572 reports with a coded outcome, Ongoing is the leading category at 36.9%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Lyme Vaccine.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial